Cita APA

Metz, M., Bernstein, J., Giménez-Arnau, A. M., Hide, M., Maurer, M., Sitz, K., . . . Severin, T. (2022). Ligelizumab improves angioedema, disease severity and quality-of-life in patients with chronic spontaneous urticaria.

Citación estilo Chicago

Metz, Martin|||0000-0002-4070-9976, et al. Ligelizumab Improves Angioedema, Disease Severity and Quality-of-life in Patients With Chronic Spontaneous Urticaria. 2022.

Cita MLA

Metz, Martin|||0000-0002-4070-9976, et al. Ligelizumab Improves Angioedema, Disease Severity and Quality-of-life in Patients With Chronic Spontaneous Urticaria. 2022.